Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection

Fouad Seghrouchni, Silvia Contini, Roumiana Markova, Roumiana Drenska, Khalid Sadki, Larbii Baassi, Yana Todorova, Velislava Terzieva, Marialuisa Bocchino, Giulia Cappelli, Alfonso Maria Altieri, Mario Giuseppe Alma, Abdelaziz Benjouad, Francesca Mariani, Bogdan Petrunov, Vittorio Colizzi, Rajae El Aouad, Cesare Saltini, Massimo Amicosante

Research output: Contribution to journalArticle

Abstract

In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially expressed during MTB-intracellular growth might provide new targets for the diagnosis of MTB-infection. To this end seventy-five multiepitopic HLA-promiscuous MTB-peptides were designed by quantitative implemented peptide-binding motif analysis from 3 MTB-protein genes expressed in activated human macrophages (MA), 4 genes expressed during growth in non-activated human macrophages (MN-A), 12 housekeeping genes (HKG) and 6 genes of the RD1 region (RD1) as control. ELISpot for IFN-was performed to measure the responses of PBMCs deriving from 45 patients affected by active tuberculosis and 34 controls. In active-TB patients, the mean response to RD1-derived peptides was higher than that to either MA (p <0.01), MN-A (p <0.008) or HKG (p <0.01) derived peptides. In TST-positive subjects all selected peptides elicited significant IFN-T-cell responses (p <0.02 compared to TST-negatives), but without differences between the subgroups. Further, T-cell responses to RD1 peptides were lower in the 23 active-TB treated patients than in the untreated ones (p <0.01). The response to MA peptides in treated active-TB was higher than when untreated (p <0.01). These results demonstrate that the use of in vitro models of MTB-intracellular infection to select MTB gene products for further in silico and in vitro assessment of their immunogenicity have the potential to identify novel antigens amenable to the design of new tools for diagnosis and monitoring of tuberculosis.

Original languageEnglish
Pages (from-to)210-217
Number of pages8
JournalTuberculosis
Volume89
Issue number3
DOIs
Publication statusPublished - May 2009

Fingerprint

Mycobacterium tuberculosis
Macrophages
Peptides
Infection
Genes
Essential Genes
Tuberculosis
T-Lymphocytes
Proteins
Growth
Computer Simulation
Genome
Antigens
In Vitro Techniques

Keywords

  • ELISpot
  • Macrophage-induced mycobacterial genes
  • Peptide-binding motifs
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Seghrouchni, F., Contini, S., Markova, R., Drenska, R., Sadki, K., Baassi, L., ... Amicosante, M. (2009). Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. Tuberculosis, 89(3), 210-217. https://doi.org/10.1016/j.tube.2009.03.005

Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. / Seghrouchni, Fouad; Contini, Silvia; Markova, Roumiana; Drenska, Roumiana; Sadki, Khalid; Baassi, Larbii; Todorova, Yana; Terzieva, Velislava; Bocchino, Marialuisa; Cappelli, Giulia; Altieri, Alfonso Maria; Alma, Mario Giuseppe; Benjouad, Abdelaziz; Mariani, Francesca; Petrunov, Bogdan; Colizzi, Vittorio; El Aouad, Rajae; Saltini, Cesare; Amicosante, Massimo.

In: Tuberculosis, Vol. 89, No. 3, 05.2009, p. 210-217.

Research output: Contribution to journalArticle

Seghrouchni, F, Contini, S, Markova, R, Drenska, R, Sadki, K, Baassi, L, Todorova, Y, Terzieva, V, Bocchino, M, Cappelli, G, Altieri, AM, Alma, MG, Benjouad, A, Mariani, F, Petrunov, B, Colizzi, V, El Aouad, R, Saltini, C & Amicosante, M 2009, 'Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection', Tuberculosis, vol. 89, no. 3, pp. 210-217. https://doi.org/10.1016/j.tube.2009.03.005
Seghrouchni, Fouad ; Contini, Silvia ; Markova, Roumiana ; Drenska, Roumiana ; Sadki, Khalid ; Baassi, Larbii ; Todorova, Yana ; Terzieva, Velislava ; Bocchino, Marialuisa ; Cappelli, Giulia ; Altieri, Alfonso Maria ; Alma, Mario Giuseppe ; Benjouad, Abdelaziz ; Mariani, Francesca ; Petrunov, Bogdan ; Colizzi, Vittorio ; El Aouad, Rajae ; Saltini, Cesare ; Amicosante, Massimo. / Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. In: Tuberculosis. 2009 ; Vol. 89, No. 3. pp. 210-217.
@article{075c4160851a46a1a72406cf3dd46a5f,
title = "Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection",
abstract = "In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially expressed during MTB-intracellular growth might provide new targets for the diagnosis of MTB-infection. To this end seventy-five multiepitopic HLA-promiscuous MTB-peptides were designed by quantitative implemented peptide-binding motif analysis from 3 MTB-protein genes expressed in activated human macrophages (MA), 4 genes expressed during growth in non-activated human macrophages (MN-A), 12 housekeeping genes (HKG) and 6 genes of the RD1 region (RD1) as control. ELISpot for IFN-was performed to measure the responses of PBMCs deriving from 45 patients affected by active tuberculosis and 34 controls. In active-TB patients, the mean response to RD1-derived peptides was higher than that to either MA (p <0.01), MN-A (p <0.008) or HKG (p <0.01) derived peptides. In TST-positive subjects all selected peptides elicited significant IFN-T-cell responses (p <0.02 compared to TST-negatives), but without differences between the subgroups. Further, T-cell responses to RD1 peptides were lower in the 23 active-TB treated patients than in the untreated ones (p <0.01). The response to MA peptides in treated active-TB was higher than when untreated (p <0.01). These results demonstrate that the use of in vitro models of MTB-intracellular infection to select MTB gene products for further in silico and in vitro assessment of their immunogenicity have the potential to identify novel antigens amenable to the design of new tools for diagnosis and monitoring of tuberculosis.",
keywords = "ELISpot, Macrophage-induced mycobacterial genes, Peptide-binding motifs, Tuberculosis",
author = "Fouad Seghrouchni and Silvia Contini and Roumiana Markova and Roumiana Drenska and Khalid Sadki and Larbii Baassi and Yana Todorova and Velislava Terzieva and Marialuisa Bocchino and Giulia Cappelli and Altieri, {Alfonso Maria} and Alma, {Mario Giuseppe} and Abdelaziz Benjouad and Francesca Mariani and Bogdan Petrunov and Vittorio Colizzi and {El Aouad}, Rajae and Cesare Saltini and Massimo Amicosante",
year = "2009",
month = "5",
doi = "10.1016/j.tube.2009.03.005",
language = "English",
volume = "89",
pages = "210--217",
journal = "Tuberculosis",
issn = "1472-9792",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection

AU - Seghrouchni, Fouad

AU - Contini, Silvia

AU - Markova, Roumiana

AU - Drenska, Roumiana

AU - Sadki, Khalid

AU - Baassi, Larbii

AU - Todorova, Yana

AU - Terzieva, Velislava

AU - Bocchino, Marialuisa

AU - Cappelli, Giulia

AU - Altieri, Alfonso Maria

AU - Alma, Mario Giuseppe

AU - Benjouad, Abdelaziz

AU - Mariani, Francesca

AU - Petrunov, Bogdan

AU - Colizzi, Vittorio

AU - El Aouad, Rajae

AU - Saltini, Cesare

AU - Amicosante, Massimo

PY - 2009/5

Y1 - 2009/5

N2 - In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially expressed during MTB-intracellular growth might provide new targets for the diagnosis of MTB-infection. To this end seventy-five multiepitopic HLA-promiscuous MTB-peptides were designed by quantitative implemented peptide-binding motif analysis from 3 MTB-protein genes expressed in activated human macrophages (MA), 4 genes expressed during growth in non-activated human macrophages (MN-A), 12 housekeeping genes (HKG) and 6 genes of the RD1 region (RD1) as control. ELISpot for IFN-was performed to measure the responses of PBMCs deriving from 45 patients affected by active tuberculosis and 34 controls. In active-TB patients, the mean response to RD1-derived peptides was higher than that to either MA (p <0.01), MN-A (p <0.008) or HKG (p <0.01) derived peptides. In TST-positive subjects all selected peptides elicited significant IFN-T-cell responses (p <0.02 compared to TST-negatives), but without differences between the subgroups. Further, T-cell responses to RD1 peptides were lower in the 23 active-TB treated patients than in the untreated ones (p <0.01). The response to MA peptides in treated active-TB was higher than when untreated (p <0.01). These results demonstrate that the use of in vitro models of MTB-intracellular infection to select MTB gene products for further in silico and in vitro assessment of their immunogenicity have the potential to identify novel antigens amenable to the design of new tools for diagnosis and monitoring of tuberculosis.

AB - In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially expressed during MTB-intracellular growth might provide new targets for the diagnosis of MTB-infection. To this end seventy-five multiepitopic HLA-promiscuous MTB-peptides were designed by quantitative implemented peptide-binding motif analysis from 3 MTB-protein genes expressed in activated human macrophages (MA), 4 genes expressed during growth in non-activated human macrophages (MN-A), 12 housekeeping genes (HKG) and 6 genes of the RD1 region (RD1) as control. ELISpot for IFN-was performed to measure the responses of PBMCs deriving from 45 patients affected by active tuberculosis and 34 controls. In active-TB patients, the mean response to RD1-derived peptides was higher than that to either MA (p <0.01), MN-A (p <0.008) or HKG (p <0.01) derived peptides. In TST-positive subjects all selected peptides elicited significant IFN-T-cell responses (p <0.02 compared to TST-negatives), but without differences between the subgroups. Further, T-cell responses to RD1 peptides were lower in the 23 active-TB treated patients than in the untreated ones (p <0.01). The response to MA peptides in treated active-TB was higher than when untreated (p <0.01). These results demonstrate that the use of in vitro models of MTB-intracellular infection to select MTB gene products for further in silico and in vitro assessment of their immunogenicity have the potential to identify novel antigens amenable to the design of new tools for diagnosis and monitoring of tuberculosis.

KW - ELISpot

KW - Macrophage-induced mycobacterial genes

KW - Peptide-binding motifs

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=67349119048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349119048&partnerID=8YFLogxK

U2 - 10.1016/j.tube.2009.03.005

DO - 10.1016/j.tube.2009.03.005

M3 - Article

C2 - 19447677

AN - SCOPUS:67349119048

VL - 89

SP - 210

EP - 217

JO - Tuberculosis

JF - Tuberculosis

SN - 1472-9792

IS - 3

ER -